In one study, seven patients (26%) presenting with foot drop had had recent IM injections in the buttock. An additional 20 patients (74%) presented much later (Fatunde & Familusi, 2001).

Scientists have got success with a new injection of HIV. Taking this injection once a year can reduce the risk of HIV infection for 12 months. In the stage 1 clinical trial, scientists... Read more ...

Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two injections per year to one against HIV. "It is a hopeful step and the study data are ...

Quebec is the first province to publicly cover costs of long-acting injectable HIV prevention medication Apretude. Experts ...

The FDA cleared the investigational new drug (IND) application for EVM14. EVM14 is an off-the-shelf tumor-associated antigen ...

It tested two new formulations of lenacapavir. These formulations were given as two intramuscular injections to 40 adults.

This column provides an overview of restraint in psittacine birds and administration of subcutaneous fluids and intramuscular injections. The principles described here may be also used on other ...

A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...

Gilead Sciences' data on two novel, once-yearly formulations of lenacapavir for PrEP support the further development of the drug.

A 25-year-old male patient presented with foot drop indicative of a sciatic nerve injury following gluteal intramuscular (IM) injections. Blood tests and magnetic resonance imaging of his spine ...